Last edition
News about
Maiva Pharma Raises INR 1,000 Crore from Fundraising
Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).
Bound Tree Medical to Acquire QuadMed
Bound Tree Medical announced that the company has signed a definitive agreement to acquire QuadMed, Inc. Following a thoughtful integration period of 60-90 days, Bound Tree will seamlessly assume full operation of QuadMed's business, serving customers serving customers under the Bound Tree brand name.
PainTEQ Gets Two New Patents for the LinQ Procedure, Advancing Treatments for SI Joint Dysfunction
These patents mark a notable step forward in medical device innovation, offering new hope to thousands suffering from debilitating lower back pain.
Granules India Limited Gets ANDA Approval for Colchicine Capsules
Granules India Ltd. has declared that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, for Colchicine Capsules, 0.6 mg.
United Imaging Receives FDA Clearance for uMR Jupiter 5T MRI System
The uMR Jupiter is hailed as the first ultra-high field system cleared for whole-body applications, setting a new standard in the field.
Medison Pharma and Alnylam Pharmaceuticals Expand Partnership to Reach More Patients Globally
Medison has developed a unique commercialization platform focused on delivering cutting-edge treatments for rare and severe diseases.
First Infant Pyeloplasty Done Using SSi Mantra Surgical Robotic System
SS Innovations International has announced the successful performance of the first pyeloplasty procedure performed on an infant utilizing its flagship SSi Mantra Surgical Robotic System.
TriLink Signs Non-Exclusive License and Supply Agreement with Lonza
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.
INCOG Facility Receives FDA Approval for Commercial Drug Production
INCOG BioPharma Services has announced that its sterile injectable manufacturing facility has received approval from the US Food and Drug Administration (FDA) to produce a commercially approved drug product.
AEYE Health Receives FDA Clearance for Autonomous AI Diagnosis of Diabetic Retinopathy
AEYE-DS is the sole solution enabling screenings with just one image per eye, boasting over 99 percent imageability.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy